Tiny Cargo

Tiny Cargo, founded in Roanoke, Virginia, is a pioneering medical organization focused on revolutionizing drug delivery systems. Their core mission is to leverage non-immunogenic bovine milk-derived exosomes for the protected oral or IV-based delivery of potent therapeutics. This innovative approach aims to treat a range of diseases including ischemic heart disease, gastrointestinal radiation disease, and glioblastoma multiforme. Tiny Cargo's vision is to harness the natural healing properties of milk exosomes to bypass internal barriers in the human body, making advanced treatments more effective and accessible.

Notable affiliated individuals include leading researchers and scientists in the field of exosome technology. The company has attracted investment from key players in the biotech and pharmaceutical industries, recognizing the transformative potential of their technology. Among their key achievements is the development of an industrial-scale production process for milk exosomes, a world first. Tiny Cargo's impact lies in its potential to significantly improve therapeutic outcomes for patients with severe and complex diseases, marking a significant advancement in medical science and drug delivery methodologies.